There are several identified binding partners for FGFR2, some of them are TACC3 and CCDC6 in cholangiocarcinoma [166,168] and BICC1 in hepatocarcinoma and colorectal cancer [169]. The gene discussed is FGFR2; the disease is cholangiocarcinoma.